Does Regence Cover Viagra?

What Regence Actually Covers for Erectile Dysfunction

Regence BlueCross BlueShield covers erectile dysfunction medications on a plan-by-plan basis. Generic sildenafil, the bioequivalent of Viagra, appears on most commercial formularies at Tier 2 or Tier 3. Brand-name Viagra is a different story. Pfizer's branded product is excluded from many Regence commercial formularies outright, or placed at Tier 4 or Tier 5 with costs that can exceed $400 for a 30-pill supply without additional negotiation.

The FDA approved sildenafil citrate for erectile dysfunction in March 1998 under the brand name Viagra, and generic versions entered the U.S. market in December 2017 after Pfizer's patent exclusivity expired. [1] Since then, generic sildenafil has become the standard formulary option across most major insurers, including Regence.

Erectile dysfunction affects an estimated 30 million men in the United States, according to the National Institute of Diabetes and Digestive and Kidney Diseases. [2] The condition frequently co-occurs with cardiovascular disease, diabetes, and hypogonadism, which gives prescribers a solid clinical rationale for coverage documentation. A 2021 study published in the Journal of Sexual Medicine found that men with type 2 diabetes had a 3.5-fold higher prevalence of moderate-to-severe ED compared with age-matched controls without diabetes. [3]

Coverage for sildenafil under Regence depends on three variables: the specific plan document (group vs. individual vs. Medicare Advantage), the state where the plan is issued, and whether the employer sponsor has opted out of ED drug coverage. Some self-funded employer plans administered by Regence explicitly exclude drugs classified as "lifestyle medications," a category that can include PDE5 inhibitors like sildenafil, tadalafil (Cialis), and avanafil (Stendra).

How to Find Out if Your Specific Regence Plan Covers Sildenafil

Check your Summary of Benefits and Coverage document or log into the Regence member portal at regence.com and use the formulary search tool. Type "sildenafil" first, then "Viagra," and note the tier, any quantity limits, and whether a prior authorization (PA) icon appears next to the drug.

If you do not have portal access, call the member services number on the back of your insurance card. Ask specifically: "Is sildenafil covered under my pharmacy benefit? What tier? Is prior authorization required? What is my copay for a 30-day supply at a preferred pharmacy?" Write down the representative's name and the call reference number.

The Centers for Medicare and Medicaid Services requires all insurers to maintain publicly accessible formulary files. [4] Regence submits these files for its Medicare products; commercial plan formularies are available through employer HR departments or the Regence broker portal.

The HealthRX Clinical Coverage Checklist for Regence ED Medication Requests:

1. Confirm the ICD-10 diagnosis code is N52.9 (erectile dysfunction, unspecified) or a more specific sub-code such as N52.01 (erectile dysfunction due to arterial insufficiency).
2. Verify the drug name on the formulary search is "sildenafil citrate" rather than "Viagra."
3. Note the tier and any quantity limits (most plans cap at 6 to 8 tablets per 30 days).
4. Ask whether a step-therapy requirement exists, meaning the plan may require a 30-day trial of a lower-tier medication before approving a preferred dose.
5. Confirm whether your prescribing provider has submitted the PA request or whether the pharmacy initiated it.
6. Request an expedited PA (72-hour decision) rather than standard (14 days) if a physician documents clinical urgency.

Prior Authorization: What Regence Requires

Prior authorization for sildenafil under Regence plans typically requires documentation of an organic or mixed etiology for erectile dysfunction. Pure psychogenic ED may face additional scrutiny. The PA request form generally asks for: the patient's diagnosis code, a description of prior treatments tried (including lifestyle changes, testosterone evaluation, and any cardiovascular workup), current comorbidities, and the prescriber's attestation that the medication is medically necessary.

According to the American Urological Association's 2018 Guideline on Erectile Dysfunction, first-line therapy for ED includes PDE5 inhibitors as the preferred oral pharmacological option, a position that has not changed through the 2024 guideline addendum. [5] This guideline language is your prescriber's strongest tool when writing the PA letter. A direct quote from AUA guidelines stating that "PDE5 inhibitors are first-line therapy" can anchor the medical necessity argument.

Regence typically issues a PA decision within 3 to 14 business days. Expedited requests, when a prescriber certifies that a standard review timeline could seriously jeopardize the member's health, require a decision within 72 hours under Washington, Oregon, Idaho, and Utah state insurance regulations where Regence operates. [6]

If the PA is denied, request a detailed denial notice in writing. The denial must specify the exact clinical criteria the request failed to meet. This document drives your appeal.

Copay and Out-of-Pocket Cost Breakdown

Assuming sildenafil is covered under your Regence plan, actual copay depends on tier placement:

Tier 2 (preferred generic): Roughly $10 to $25 for a 30-day supply at an in-network pharmacy, or $0 to $15 through Regence's preferred mail-order pharmacy program.

Tier 3 (non-preferred generic or preferred brand): Roughly $40 to $65 for a 30-day supply.

Tier 4 (non-preferred brand): Roughly $80 to $150 or 40 to 50 percent coinsurance, whichever is greater.

Most Regence plans place a quantity limit of 6 tablets per 30 days for sildenafil 100 mg, though some plans allow up to 8 tablets. Requesting 50 mg tablets taken as two separate 25 mg doses is a clinical workaround some providers use to extend the supply, though this is off-label splitting practice and should be discussed with your prescribing physician.

The FDA-approved sildenafil dosing range for erectile dysfunction is 25 mg to 100 mg taken approximately one hour before sexual activity, with a maximum of one dose per 24-hour period. [7] Starting at 50 mg is the standard recommendation, with dose adjustment based on response and tolerability.

Generic Sildenafil vs. Brand Viagra: Is There a Clinical Difference?

No clinically meaningful difference exists between FDA-approved generic sildenafil and brand-name Viagra for most patients. The FDA's generic drug approval standards require bioequivalence: the generic product must deliver 80 to 125 percent of the reference drug's area-under-the-curve (AUC) and peak plasma concentration (Cmax) within that range, and most approved generics fall within 3 to 5 percent of the brand. [8]

Multiple manufacturers now produce generic sildenafil, including Teva, Greenstone, and Aurobindo. All carry the same FDA-approved labeling, contraindications (concurrent nitrate use is an absolute contraindication), and black box warnings.

For the approximately 3 to 5 percent of patients who report a perceived difference in efficacy between the brand and a specific generic, the variation may relate to inactive excipients rather than the active moiety. Switching to a different generic manufacturer, rather than returning to brand-name Viagra, is typically the appropriate first step.

What to Do if Regence Denies Coverage

A denial is not a final answer. Under the Employee Retirement Income Security Act (ERISA) and applicable state insurance codes, you have the right to an internal appeal and, if unsuccessful, an external independent review. [9]

Steps to follow after a denial:

First, read the Explanation of Benefits (EOB) carefully. Identify whether the denial is based on "not medically necessary," "formulary exclusion," "step therapy not completed," or "prior authorization not obtained." Each denial type requires a different appeal strategy.

For a "not medically necessary" denial, the prescribing physician should submit a letter citing the AUA guideline language on PDE5 inhibitors as first-line therapy, the patient's documented organic etiology (e.g., diabetes, atherosclerosis, low testosterone, post-prostatectomy status), and failed response to lifestyle modifications. Including objective data such as an International Index of Erectile Function (IIEF) score below 21, which indicates at least mild ED, strengthens the appeal significantly. [10]

For a formulary exclusion, check whether the plan document contains a "formulary exception" process. Regence commercial plans operating under Washington State Insurance Code chapter 48.43 RCW must allow formulary exceptions when a covered drug is not therapeutically equivalent or causes adverse effects in a specific patient. [6]

External appeals in Washington, Oregon, Idaho, and Utah go to independent review organizations certified by state insurance departments. Nationally, the federal external appeal process applies to most ERISA-governed group health plans. The external reviewer's decision is binding on the insurer.

Medicare Advantage and Regence: Does Part D Cover Viagra?

This requires a separate analysis. Medicare Part D plans, including Medicare Advantage Prescription Drug (MAPD) plans administered by Regence, are explicitly prohibited from covering drugs used for sexual or erectile dysfunction under 42 CFR 423.100 unless the drug is being used for a non-exclusion indication. [11] Sildenafil 20 mg (sold as Revatio) is FDA-approved for pulmonary arterial hypertension (PAH) and is covered under Part D for that diagnosis. Sildenafil prescribed specifically for erectile dysfunction is a non-covered service under all Medicare Part D plans.

If you have Medicare and need sildenafil for ED, your options are self-pay generic pricing (GoodRx and similar discount programs often reduce 100 mg sildenafil to $15 to $30 for a 30-day supply at major chain pharmacies), manufacturer assistance programs, or community health center pharmacies that operate on sliding-scale pricing.

Telehealth Prescriptions and Regence Pharmacy Benefits

Regence accepts prescriptions for sildenafil issued by telehealth providers licensed in the patient's state of residence, subject to the same formulary, prior authorization, and quantity limit rules as in-person prescriptions. The DEA's temporary COVID-era telemedicine flexibilities for non-controlled substances remain in effect for drugs like sildenafil, which is not a federally scheduled controlled substance. [12]

Several direct-to-consumer telehealth platforms, including those connected to HealthRX's clinical network, can prescribe sildenafil after a synchronous or asynchronous evaluation. If your Regence plan covers sildenafil, provide the telehealth prescriber's NPI number to your pharmacy, and the claim processes identically to an in-person prescription. Confirm the prescribing provider is licensed in your state, because out-of-state prescriptions for non-controlled substances may still trigger pharmacy rejection on some Regence plan adjudication systems.

Tadalafil and Avanafil: Covered Alternatives to Consider

If sildenafil is not covered or poorly tolerated, Regence formularies often include generic tadalafil (the bioequivalent of Cialis) and, less commonly, avanafil (Stendra, for which no generic exists as of early 2025).

Generic tadalafil offers a pharmacokinetic advantage: its half-life of approximately 17.5 hours versus sildenafil's 3 to 5 hours allows dosing flexibility, including once-daily low-dose use at 2.5 mg or 5 mg for men who prefer spontaneous sexual activity without timed dosing. [13] A 2016 Cochrane systematic review of 82 trials (N=17,599) found that all approved PDE5 inhibitors demonstrated statistically significant improvement in IIEF erectile function domain scores compared with placebo, with no single agent showing a clear efficacy advantage across the full population. [14]

Avanafil has the fastest onset of the approved PDE5 inhibitors, with some patients reporting effect as early as 15 minutes after a 200 mg dose, versus 30 to 60 minutes for sildenafil. [15] However, brand-only status makes avanafil expensive without coverage, typically $400 or more per 10-tablet pack at retail pharmacy prices.

When Sildenafil Requires a Cardiovascular Clearance

Not every man can take sildenafil safely. The Princeton III Consensus Panel guidelines, updated in 2012 and still referenced in current AHA cardiology practice, stratify cardiovascular risk before prescribing PDE5 inhibitors. [16] Low-risk patients (stable coronary artery disease, mild hypertension controlled on one or two agents, no recent cardiac event within 90 days) may proceed with PDE5 inhibitor therapy. Intermediate-risk patients require further evaluation. High-risk patients, including those with unstable angina or recent myocardial infarction within 2 weeks, should not use sildenafil until cardiovascular stabilization.

The absolute contraindication is concurrent use of any nitrate medication, including nitroglycerin, isosorbide mononitrate, and isosorbide dinitrate, in any form, including sublingual, transdermal, or oral routes. Co-administration can produce a clinically catastrophic drop in systolic blood pressure. This contraindication is FDA-labeled and has not changed since sildenafil's original approval. [7]

Alpha-blockers also warrant caution. Men taking tamsulosin (Flomax) for benign prostatic hyperplasia at a dose of 0.4 mg daily may take sildenafil, but the prescriber should start at the lowest available dose (25 mg) and counsel the patient on postural hypotension risk, particularly in the first hour after dosing.

A complete medication reconciliation before prescribing, checking specifically for nitrates, alpha-blockers, strong CYP3A4 inhibitors like ketoconazole or ritonavir, and any other antihypertensive agents, is the standard of care. CYP3A4 inhibitors can increase sildenafil plasma concentrations by two- to ten-fold, necessitating a maximum dose of 25 mg per 48 hours in patients taking potent inhibitors. [7]

Documenting Medical Necessity for the Best Coverage Outcome

The single most effective step a patient can take is asking the prescribing provider to document the specific organic etiology of ED in the chart note and on the PA request. Vague language like "erectile dysfunction" without etiological context gives the insurance reviewer little clinical basis to approve. Specific language such as "erectile dysfunction secondary to type 2 diabetes mellitus (E11.9), confirmed by IIEF-5 score of 14, with failed response to lifestyle modification over 12 weeks" provides a complete clinical picture.

Testosterone levels matter. The Endocrine Society's 2018 Clinical Practice Guideline on testosterone therapy recommends evaluating total testosterone in men with ED before initiating pharmacotherapy, because hypogonadal men may respond poorly to PDE5 inhibitors alone and may require testosterone supplementation to restore adequate response. [17] Including a testosterone laboratory result in the PA package, whether normal or low, demonstrates thorough evaluation and can preempt secondary denial based on "incomplete workup."

If prior authorization is approved, confirm the approval period. Most Regence PA approvals for sildenafil run 12 months, after which reauthorization may be required. Set a calendar reminder 60 days before expiration to allow the prescribing provider time to resubmit without a coverage gap.